Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children’s Oncology Group Trials

Danielle S. Bitterman(Brigham and Women's Hospital), Daphne A. Haas‐Kogan(Neurology, Inc), Wendy B. London(Dana-Farber Cancer Institute), Pei-Chi Kao(Dana-Farber Cancer Institute), Fran Laurie, Kira Bona(Dana-Farber Cancer Institute), Stephanie Terezakis(University of Minnesota)
JAMA Oncology
August 6, 2020
10.1001/jamaoncol.2020.2259
Cited by 36

Related Papers

Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Artificial intelligence in radiation oncology
|Nature Reviews Clinical Oncology|2020|399
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia
|JAMA|2021|358
The TRIPOD-LLM reporting guideline for studies using large language models
|Nature Medicine|2025|340
Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer
|Journal of the American College of Cardiology|2019|270